IFP Advisors, Inc - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,840
-69.7%
2,000
-50.0%
0.00%
Q2 2023$12,660
+29.4%
4,000
+100.0%
0.00%
Q1 2023$9,780
+69757.1%
2,000
-33.3%
0.00%
Q4 2022$14
-99.9%
3,000
+11.1%
0.00%
Q3 2022$13,000
+8.3%
2,700
+8.0%
0.00%
Q2 2022$12,000
-50.0%
2,500
-50.0%
0.00%
Q1 2022$24,000
+380.0%
5,000
+100.0%
0.00%
Q4 2021$5,000
-50.0%
2,5000.0%0.00%
Q3 2021$10,000
+400.0%
2,500
+400.0%
0.00%
Q2 2021$2,000
+100.0%
5000.0%0.00%
Q1 2021$1,0000.0%5000.0%0.00%
Q4 2020$1,0000.0%5000.0%0.00%
Q3 2020$1,000
-50.0%
5000.0%0.00%
Q2 2020$2,000
+100.0%
5000.0%0.00%
Q1 2020$1,0000.0%5000.0%0.00%
Q4 2019$1,000
-50.0%
5000.0%0.00%
Q3 2019$2,000
-90.5%
500
-88.1%
0.00%
-100.0%
Q1 2019$21,000
-27.6%
4,200
-46.2%
0.00%
+50.0%
Q4 2018$29,000
-42.0%
7,800
-5.5%
0.00%0.0%
Q3 2018$50,000
+47.1%
8,254
+55.7%
0.00%
+100.0%
Q2 2018$34,000
+100.0%
5,300
+1.9%
0.00%0.0%
Q1 2018$17,0000.0%5,2000.0%0.00%0.0%
Q4 2017$17,000
+30.8%
5,200
-13.3%
0.00%0.0%
Q3 2017$13,000
-13.3%
6,0000.0%0.00%0.0%
Q2 2017$15,000
+7.1%
6,0000.0%0.00%0.0%
Q1 2017$14,000
+133.3%
6,0000.0%0.00%
Q4 2016$6,000
-25.0%
6,000
-14.3%
0.00%
Q3 2016$8,000
-20.0%
7,000
+4.5%
0.00%
-100.0%
Q2 2016$10,000
-52.4%
6,700
+59.5%
0.00%
-66.7%
Q1 2016$21,000
+75.0%
4,200
-43.6%
0.00%
+200.0%
Q4 2015$12,0007,4500.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders